Valerie B.  Jarrett net worth and biography

Valerie Jarrett Biography and Net Worth

Ms. Jarrett has served as a Distinguished Senior Fellow at the University of Chicago Law School since January 2018 and is the Chief Executive Officer for The Barack Obama Foundation. From January 2009 to January 2017, Ms. Jarrett served as Senior Advisor to the President of the United States, where she co-chaired the transition team for the new administration, oversaw the Office of Public Engagement and Intergovernmental Affairs and chaired the White House Council on Women and Girls. Prior to joining the administration of the President of the United States, Ms. Jarrett served in various senior positions, including Chief Executive Officer of The Habitat Company, a Chicago real estate development and management firm. She previously was Deputy Chief of Staff for the Mayor of Chicago, served as Commissioner of the Chicago Department of Planning and Development and chaired the Chicago Transit Board. Ms. Jarrett has served on the boards of directors of Ralph Lauren Corporation, a premium lifestyle products company, since October 2020 and Sweetgreen Inc., a healthy restaurant and lifestyle brand, since August 2020. She also serves on the board of Ariel Investments, LLC, a private investment company. She was formerly on the board of directors of 2U, Inc., an education technology company, from December 2017 to October 2021, and Lyft Inc., a ride sharing service company, from July 2017 to October 2023.

What is Valerie B. Jarrett's net worth?

The estimated net worth of Valerie B. Jarrett is at least $78,871.20 as of January 29th, 2024. Ms. Jarrett owns 4,456 shares of Walgreens Boots Alliance stock worth more than $78,871 as of April 16th. This net worth approximation does not reflect any other investments that Ms. Jarrett may own. Learn More about Valerie B. Jarrett's net worth.

How do I contact Valerie B. Jarrett?

The corporate mailing address for Ms. Jarrett and other Walgreens Boots Alliance executives is 108 Wilmot Road, Deerfield IL, 60015. Walgreens Boots Alliance can also be reached via phone at (847) 315-3700 and via email at [email protected]. Learn More on Valerie B. Jarrett's contact information.

Has Valerie B. Jarrett been buying or selling shares of Walgreens Boots Alliance?

Valerie B. Jarrett has not been actively trading shares of Walgreens Boots Alliance within the last three months. Most recently, on Monday, January 29th, Valerie B. Jarrett bought 4,456 shares of Walgreens Boots Alliance stock. The stock was acquired at an average cost of $22.44 per share, with a total value of $99,992.64. Following the completion of the transaction, the director now directly owns 4,456 shares of the company's stock, valued at $99,992.64. Learn More on Valerie B. Jarrett's trading history.

Who are Walgreens Boots Alliance's active insiders?

Walgreens Boots Alliance's insider roster includes Kevin Ban (EVP), Ornella Barra (COO), Rosalind Brewer (CEO), John Driscoll (EVP), Richard Gates (SVP), Valerie Jarrett (Director), Marco Pagni (CAO), Nancy Schlichting (Director), Timothy Wentworth (CEO), and Kathleen Wilson-Thompson (EVP). Learn More on Walgreens Boots Alliance's active insiders.

Are insiders buying or selling shares of Walgreens Boots Alliance?

During the last twelve months, Walgreens Boots Alliance insiders bought shares 5 times. They purchased a total of 28,628 shares worth more than $659,610.88. During the last twelve months, insiders at the pharmacy operator sold shares 2 times. They sold a total of 16,209 shares worth more than $371,017.45. The most recent insider tranaction occured on April, 11th when Director Inderpal S Bhandari bought 3,000 shares worth more than $54,150.00. Insiders at Walgreens Boots Alliance own 17.4% of the company. Learn More about insider trades at Walgreens Boots Alliance.

Information on this page was last updated on 4/11/2024.

Valerie B. Jarrett Insider Trading History at Walgreens Boots Alliance

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/29/2024Buy4,456$22.44$99,992.644,456View SEC Filing Icon  
See Full Table

Valerie B. Jarrett Buying and Selling Activity at Walgreens Boots Alliance

This chart shows Valerie B Jarrett's buying and selling at Walgreens Boots Alliance by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Walgreens Boots Alliance Company Overview

Walgreens Boots Alliance logo
Walgreens Boots Alliance, Inc. operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise. The International segment offers sale of prescription drugs and health and wellness, beauty, personal care, and other consumer products outside the United States; and operates pharmacy-led health and beauty retail businesses under the Boots brand stores in the United Kingdom, the Republic of Ireland, and Thailand, as well as the Benavides brand in Mexico and the Ahumada brand in Chile. The U.S. Healthcare segment provides VillageMD, a national provider of value-based care with primary, multi-specialty, and urgent care providers serving patients in traditional clinic settings, in patients' homes and online appointments; Shields, a specialty pharmacy integrator and accelerator for hospitals; and CareCentrix, a participant in the post-acute and home care management sectors. Walgreens Boots Alliance, Inc. was founded in 1909 and is headquartered in Deerfield, Illinois.
Read More

Today's Range

Now: $17.64
Low: $17.54
High: $17.83

50 Day Range

MA: $20.81
Low: $17.65
High: $23.11

2 Week Range

Now: $17.64
Low: $17.53
High: $36.14

Volume

8,546,435 shs

Average Volume

14,441,903 shs

Market Capitalization

$15.22 billion

P/E Ratio

N/A

Dividend Yield

5.60%

Beta

0.73